Back to search results

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Israel
RecruitingPHASE2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Aortic Stenosis

Locations
  • Heart Center Research Llc, Huntsville, Alabama, United States
  • Cardiovascular Res Found, Beverly Hills, California, United States
  • National Heart Institute, Beverly Hills, California, United States
  • Flourish Clinical Resrch Covin, Covina, California, United States
  • Valley Clinical Trials, Northridge, California, United States
  • Stanford University Medical Center, Palo Alto, California, United States
  • University Of California San Diego, San Diego, California, United States
  • UC San Francisco Medical Center, San Francisco, California, United States
  • Excel Medical Clinical Trials LLC, Boca Raton, Florida, United States
  • Nova Clinical Research LLC, Bradenton, Florida, United States
  • Flourish Res Acq LLC North Miami, Miami, Florida, United States
  • Inpatient Research Clinical LLC, Miami Lakes, Florida, United States
  • Advanced Research for Health Improvement LLC, Naples, Florida, United States
  • Midwest Heart and Vascular Spec, Overland Park, Kansas, United States
  • Tufts Medical Center, Boston, Massachusetts, United States
  • Massachusetts General Hospital, Boston, Massachusetts, United States
  • Massachusetts General Hospital, Boston, Massachusetts, United States
  • Brigham and Womens Hosp Harvard Med School, Boston, Massachusetts, United States
  • Brigham and Womens Hosp Harvard Med School, Boston, Massachusetts, United States
  • Henry Ford Hospital, Detroit, Michigan, United States
  • Henry Ford Hospital, Detroit, Michigan, United States
  • AA Medical Research Center, Flint, Michigan, United States
  • William Beaumont Hospital, Royal Oak, Michigan, United States
  • Minneapolis Heart Institute, Minneapolis, Minnesota, United States
  • University Of Minnesota, Minneapolis, Minnesota, United States
  • Overlook Medical Center, Summit, New Jersey, United States
  • Capital Cardiology Associates, Albany, New York, United States
  • New York Presbyterian Hospital, New York, New York, United States
  • Icahn School of Med at Mt Sinai, New York, New York, United States
  • Strong Memorial Hospital, Rochester, New York, United States
  • Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States
  • Lindner Ctr At The Christ Hosp, Cincinnati, Ohio, United States
  • Ohio State University, Columbus, Ohio, United States
  • Perelman School of Medicine, Philadelphia, Pennsylvania, United States
  • Orion Medical, Houston, Texas, United States
  • Virginia Heart, Falls Church, Virginia, United States
  • Carient Heart and Vascular, Manassas, Virginia, United States
  • Novartis Investigative Site, Innsbruck, Tyrol, Austria
  • Novartis Investigative Site, Linz, Austria
  • Novartis Investigative Site, Vienna, Austria
  • Novartis Investigative Site, Vienna, Austria
  • Novartis Investigative Site, Vienna, Austria
  • Novartis Investigative Site, Genk, Limburg, Belgium
  • Novartis Investigative Site, Yvoir, Namur, Belgium
  • Novartis Investigative Site, Aalst, Oost Vlaanderen, Belgium
  • Novartis Investigative Site, Kortrijk, West-Vlaanderen, Belgium
  • Novartis Investigative Site, Roeselare, West-Vlaanderen, Belgium
  • Novartis Investigative Site, Cambridge, Ontario, Canada
  • Novartis Investigative Site, North York, Ontario, Canada
  • Novartis Investigative Site, Ottawa, Ontario, Canada
  • Novartis Investigative Site, Montreal, Quebec, Canada
  • Novartis Investigative Site, Montreal, Quebec, Canada
  • Novartis Investigative Site, Montreal, Quebec, Canada
  • Novartis Investigative Site, Québec, Quebec, Canada
  • Novartis Investigative Site, Hradec Králové, Czechia
  • Novartis Investigative Site, Jaroměř, Czechia
  • Novartis Investigative Site, Prague, Czechia
  • Novartis Investigative Site, Prague, Czechia
  • Novartis Investigative Site, Prague, Czechia
  • Novartis Investigative Site, Esbjerg, Denmark
  • Novartis Investigative Site, Hvidovre, Denmark
  • Novartis Investigative Site, Roskilde, Denmark
  • Novartis Investigative Site, Viborg, Denmark
  • Novartis Investigative Site, Paris, France
  • Novartis Investigative Site, Paris, France
  • Novartis Investigative Site, Paris, France
  • Novartis Investigative Site, Pessac, France
  • Novartis Investigative Site, Poitiers, France
  • Novartis Investigative Site, Rennes, France
  • Novartis Investigative Site, Frankfurt am Main, Hesse, Germany
  • Novartis Investigative Site, Kaiserslautern, Rhineland-Palatinate, Germany
  • Novartis Investigative Site, Dresden, Saxony, Germany
  • Novartis Investigative Site, Leipzig, Saxony, Germany
  • Novartis Investigative Site, Ahaus, Germany
  • Novartis Investigative Site, Berlin, Germany
  • Novartis Investigative Site, Bonn, Germany
  • Novartis Investigative Site, Essen, Germany
  • Novartis Investigative Site, Hamburg, Germany
  • Novartis Investigative Site, Hamburg, Germany
  • Novartis Investigative Site, Lüneburg, Germany
  • Novartis Investigative Site, Mannheim, Germany
  • Novartis Investigative Site, München, Germany
  • Novartis Investigative Site, Münster, Germany
  • Novartis Investigative Site, Oldenburg, Germany
  • Novartis Investigative Site, Beersheba, Israel
  • Novartis Investigative Site, Haifa, Israel
  • Novartis Investigative Site, Haifa, Israel
  • Novartis Investigative Site, Jerusalem, Israel
  • Novartis Investigative Site, Jerusalem, Israel
  • Novartis Investigative Site, Nahariya, Israel
  • Novartis Investigative Site, Petah Tikva, Israel
  • Novartis Investigative Site, Ramat Gan, Israel
  • Novartis Investigative Site, Tel Aviv, Israel
  • Novartis Investigative Site, Ancona, AN, Italy
  • Novartis Investigative Site, Bergamo, BG, Italy
  • Novartis Investigative Site, Bologna, BO, Italy
  • Novartis Investigative Site, Brescia, BS, Italy
  • Novartis Investigative Site, Caserta, CE, Italy
  • Novartis Investigative Site, Cona, FE, Italy
  • Novartis Investigative Site, Pozzilli, IS, Italy
  • Novartis Investigative Site, Milan, MI, Italy
  • Novartis Investigative Site, Milan, MI, Italy
  • Novartis Investigative Site, Milan, MI, Italy
  • Novartis Investigative Site, Padova, PD, Italy
  • Novartis Investigative Site, Pordenone, PN, Italy
  • Novartis Investigative Site, Amsterdam, North Holland, Netherlands
  • Novartis Investigative Site, Amsterdam, North Holland, Netherlands
  • Novartis Investigative Site, Rotterdam, South Holland, Netherlands
  • Novartis Investigative Site, Rotterdam, South Holland, Netherlands
  • Novartis Investigative Site, Nieuwegein, Utrecht, Netherlands
  • Novartis Investigative Site, Alcabideche, Portugal
  • Novartis Investigative Site, Braga, Portugal
  • Novartis Investigative Site, Coimbra, Portugal
  • Novartis Investigative Site, Vila Nova de Gaia, Portugal
  • Novartis Investigative Site, Cáceres, Extremadura, Spain
  • Novartis Investigative Site, Córdoba, Spain
  • Novartis Investigative Site, Madrid, Spain
  • Novartis Investigative Site, Madrid, Spain
  • Novartis Investigative Site, Madrid, Spain
  • Novartis Investigative Site, Madrid, Spain
  • Novartis Investigative Site, Salamanca, Spain
  • Novartis Investigative Site, Valencia, Spain
  • Novartis Investigative Site, Basel, Switzerland
  • Novartis Investigative Site, Geneva, Switzerland
  • Novartis Investigative Site, Lausanne, Switzerland
  • Novartis Investigative Site, Lugano, Switzerland
  • Novartis Investigative Site, Zurich, Switzerland
  • Novartis Investigative Site, Reading, Berkshire, United Kingdom
  • Novartis Investigative Site, Portadown, Nothern Ireland, United Kingdom
  • Novartis Investigative Site, Edinburgh, United Kingdom
  • Novartis Investigative Site, Leicester, United Kingdom
  • Novartis Investigative Site, Liverpool, United Kingdom
  • Novartis Investigative Site, London, United Kingdom
  • Novartis Investigative Site, London, United Kingdom
  • Novartis Investigative Site, Londonderry, United Kingdom
  • Novartis Investigative Site, Manchester, United Kingdom
  • Novartis Investigative Site, Middlesbrough, United Kingdom
  • Novartis Investigative Site, Norwich, United Kingdom
  • Novartis Investigative Site, Tyne and Wear, United Kingdom
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)